Schinkel A H
Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Semin Cancer Biol. 1997 Jun;8(3):161-70. doi: 10.1006/scbi.1997.0068.
The mammalian drug-transporting or mdr1-type P-glycoproteins can extrude a range of structurally diverse, toxic xenobiotic compounds from cells. Our analysis of knockout mice lacking one or both of the mdr1-type P-glycoproteins indicates that a major function of these proteins is the protection of organisms against many of the toxic xenobiotics to which they can potentially be exposed in nature. P-glycoprotein confers protection by limiting the uptake of compounds from the gastrointestinal tract, and by stimulating excretion of compounds in the liver, kidney, and intestine. Moreover, P-glycoprotein in the blood-brain barrier and other blood-tissue barriers protects sensitive organs from exposure to toxic compounds that may have entered the bloodstream. Although we cannot exclude additional physiological functions for mdr1-type P-glycoproteins, these are not vital, since the mdr1-deficient mice are viable and fertile, and do not display obvious phenotypic abnormalities other than hypersensitivity to drugs.
哺乳动物的药物转运蛋白或mdr1型P-糖蛋白能够将一系列结构各异的有毒外源性化合物排出细胞。我们对缺乏一种或两种mdr1型P-糖蛋白的基因敲除小鼠的分析表明,这些蛋白的主要功能是保护生物体免受自然界中它们可能接触到的许多有毒外源性物质的侵害。P-糖蛋白通过限制胃肠道对化合物的摄取以及刺激肝脏、肾脏和肠道中化合物的排泄来提供保护。此外,血脑屏障和其他血组织屏障中的P-糖蛋白可保护敏感器官免受可能已进入血液的有毒化合物的侵害。虽然我们不能排除mdr1型P-糖蛋白的其他生理功能,但这些功能并非至关重要,因为mdr1基因缺陷小鼠能够存活并繁殖,除了对药物过敏外,没有表现出明显的表型异常。